About This Event

Scribe Therapeutics (Nasdaq: SCTX) visits the Nasdaq MarketSite in Times Square. Scribe is a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend healthy lifespan through disease prevention and durable therapeutic intervention, with a focus on cardiovascular and metabolic diseases.

In honor of the occasion, Benjamin Oakes, PhD, Co-founder, President, and CEO, rings the Opening Bell.